Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Background: Qiangji Jianli Fang (QJF) has been used for treatment of myasthenia gravis (MG) in China. However, our understanding of the effects of QJF against MG at the molecular level is limited. This study aims to investigate the effects of QJF treatment of MG patients on the protein, peptide and metabolite levels in serum.
著者Wang CM, Lu YH, Chen ZX, Liu XB, Lin HQ, Zhao H, Chen JY, Kwan YW, Ngai S
期刊名稱Chinese Medicine
詳細描述To ORKTS: doi:10.1186/1749-8546-7-16
出版年份2012
月份7
日期28
卷號7
出版社BioMed Central
國際標準期刊號1749-8546
語言英式英語
Web of Science 學科類別Integrative & Complementary Medicine; Pharmacology & Pharmacy

上次更新時間 2020-17-10 於 01:30